Memantine
Top View
- Memantine Upregulates BDNF and Prevents Dopamine Deficits in SIV-Infected Macaques: a Novel Pharmacological Action of Memantine
- United States Patent (19) 11 Patent Number: 5,925,634 Olney (45) Date of Patent: *Jul
- The Behavioral Pharmacology of Hallucinogens
- In Search of a New Pharmacological Treatment for Drug and Alcohol Addiction: N-Methyl-D-Aspartate (NMDA) Antagonists
- “Herbal Seizures” – Atypical Symptoms After Ibogaine Intoxication: a Case
- New Insights Into the Biology of Schizophrenia Through the Mechanism of Action of Clozapine
- Faa-Meds.Pdf
- Medications.Pdf
- Mechanisms Underlying Differential Effectiveness of Memantine and Ketamine in Rapid Antidepressant Responses
- Potentiation of General Anaesthetic Activity of Ketamine by Memantine
- High-Dose Donepezil Or Memantine: Next Step for Alzheimer’S Disease?
- Mechanisms of Nmda Receptor Inhibition by Memantine and Ketamine
- Parkinsons Disease
- Rotigotine Transdermal Patch ESCA: for the Treatment of Parkinson's Disease
- Effects of Nitrous Oxide on Dopamine Release in the Rat Nucleus Accumbens and Expectation of Reward
- The Ketamine Antidepressant Story: New Insights
- Comparison of the Effects of Ketamine and Memantine on Prolactin And
- Pharmacodynamics of Memantine: an Update G